By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Loop diuretic > Bumetanide

Bumetanide

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|655 words

Bumetanide

What is Bumetanide?

Bumetanide is a prescription medication belonging to the class of drugs known as loop diuretics, also called “water pills.” This powerful diuretic is primarily used to treat fluid retention (edema) and high blood pressure by helping the kidneys remove excess water and salt from the body. Bumetanide is considered more potent than many other diuretics and is often prescribed when other medications have proven insufficient.

Uses

Bumetanide is approved for several medical conditions:

  • Heart failure: Reduces fluid buildup in the lungs and throughout the body, helping to relieve shortness of breath and swelling
  • Kidney disease: Manages fluid retention when the kidneys cannot adequately filter excess water and sodium
  • Liver disease: Treats ascites (fluid accumulation in the abdomen) and peripheral edema associated with liver cirrhosis
  • High blood pressure: Lowers blood pressure by reducing blood volume through increased urine production
  • Pulmonary edema: Emergency treatment for fluid accumulation in the lungs, often used in hospital settings

How it works

Bumetanide works by blocking sodium and chloride reabsorption in the ascending limb of the loop of Henle, a specific part of the kidney’s filtering system. By preventing the kidneys from reabsorbing these electrolytes, the medication causes increased excretion of water, sodium, chloride, magnesium, and calcium through urine. This mechanism reduces the total volume of fluid in the body, thereby decreasing the workload on the heart and lowering blood pressure.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness or lightheadedness
  • Headache
  • Dehydration
  • Increased urination
  • Muscle cramps
  • Nausea or stomach upset
  • Weakness or fatigue
  • Low blood pressure

Serious side effects requiring immediate medical attention:

  • Severe electrolyte imbalances (low potassium, sodium, or magnesium)
  • Kidney problems or acute kidney failure
  • Hearing loss or ringing in the ears (especially with high doses)
  • Severe dehydration with confusion or rapid heartbeat
  • Signs of liver problems (yellowing of skin or eyes)

Warnings and precautions

  • Kidney and liver function: Patients with severe kidney or liver disease require careful monitoring and dose adjustments, as the medication can worsen these conditions
  • Pregnancy and breastfeeding: Classified as pregnancy category C; should only be used when benefits outweigh risks, and caution is advised during breastfeeding
  • Electrolyte monitoring: Regular blood tests are essential to monitor potassium, sodium, magnesium, and kidney function throughout treatment
  • Hearing impairment: Patients with existing hearing problems or those receiving high doses require audiometric monitoring due to risk of ototoxicity
  • Diabetes: May affect blood sugar control and can worsen glucose tolerance in diabetic patients

Interactions

  • Lithium: Bumetanide can increase lithium levels, potentially leading to lithium toxicity
  • Digoxin: Low potassium caused by bumetanide can increase the risk of digoxin toxicity and dangerous heart rhythm problems
  • Aminoglycosides (gentamicin, tobramycin): Combined use increases risk of kidney damage and hearing loss
  • NSAIDs (ibuprofen, naproxen): May reduce the effectiveness of bumetanide and increase kidney damage risk
  • ACE inhibitors and ARBs: May cause excessive blood pressure lowering and kidney problems when combined
  • Potassium supplements: Timing and dosing must be carefully managed to prevent dangerous potassium fluctuations
  • Warfarin: Bumetanide may enhance the blood-thinning effects of warfarin
  • Corticosteroids: Increase the risk of potassium depletion when used together

Check interactions with the GMJ Interaction Checker

Dosage

Adult dosages vary depending on the condition being treated and individual patient response. For edema, the typical starting dose is 0.5 to 2 mg once daily, which may be increased gradually if needed. The maximum recommended daily dose is usually 10 mg. For hypertension, lower doses of 0.5 to 2 mg daily are commonly used. Bumetanide can be taken with or without food, though taking it with food may reduce stomach upset. Dosage adjustments are often necessary for patients with kidney or liver impairment. Always follow your healthcare provider’s specific dosing instructions, as individual needs vary significantly based on medical condition, response to treatment, and other medications being taken.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Bumetanide." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/bumetanide/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Dual Doctor Couples Face Amplified Childcare Crisis in Medical Training

Dual doctor couples face amplified childcare challenges during medical training, with foundation…

Child Mortality Progress Stalls: 60 Countries Risk Missing 2030 UN Targets

New BMJ analysis reveals 60 countries unlikely to meet UN child survival…

Scientists Discover Master Clock That Controls Biological Growth and Development

Scientists have identified a genetic master clock that controls biological development timing.…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Furosemide

By
Prof. Giorgi Pkhakadze
02/06/2026

Torsemide

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up